- If a research participant has undergone prior allogeneic stem cell transplant (alloSCT), and has documented >= grade 2 graft versus host disease (GVHD) but the donor is undergoing leukapheresis, the research participant may be considered eligible (at the discretion of the study PI) provided that immunosuppressants can be tapered off completely prior to lymphodepletion